NCT00610922

Docosaexahenoic Acid and Gross Motor Milestones in Infants

RCT of Supplemented Docosahexaenoic Acid and Gross Motor Development Milestones in Healthy Infants.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,160 (actual)
• Sponsor: University of Milan · Academic / Other
• Sex: All
• Age: 1 Day – 7 Days
• Healthy volunteers: Not accepted

Summary

To examine whether daily supplement of docosahexaenoic acid throughout the first year of life may speed up the achievement of gross motor development milestones in healthy infants, a total of 1160 healthy infants randomly allocated to receive throughout the first year of life daily oral supplement of vitamin D3 (400 IU) plus docosahexaenoic acid (20 mg) or vitamin D3 (400 IU) alone. Primary outcome measure: time of achieving gross motor development milestones. Secondary outcome measure: time of achieving early fine motor development milestones and language.

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Docosahexaenoic acid (DHA)	DHA 20 mg per day through 12 months of life

Timeline

• Start date: 2005-05-01
• Primary completion: 2006-12-01
• Completion: 2006-12-01
• First posted: 2008-02-08
• Last updated: 2008-02-08